| 1 |
Romesh R. Subramanian |
Dyne Therapeutics |
13 |
| 2 |
Brian D. Therriault |
Saucony |
10 |
| 3 |
Richard J. Paolini, Jr. |
Nuclera |
8 |
| #4 |
Luke Gerdes |
Freeport Minerals |
7 |
| #4 |
Hilmar Lehnert |
Sonos |
7 |
| #6 |
Socheavy D. Heng |
Emc Ip Holding Company |
6 |
| #6 |
Steven J. Blacker |
Corindus |
6 |
| #8 |
Adam Castoreno |
Alnylam Pharmaceuticals |
5 |
| #9 |
Abraham Scaria |
Genzyme |
4 |
| #9 |
Danny Shu-Huan Lee |
Boston Scientific Scimed |
4 |
| #11 |
Jiahui Wang |
Emc Ip Holding Company |
3 |
| #11 |
Mayur Kiran Patel |
Boston Scientific Scimed |
3 |
| #11 |
Han Su |
IBM |
3 |
| #11 |
Jeffrey D. Carnes |
GE |
3 |
| #11 |
Marshall Morningstar |
Sage Therapeutics |
3 |
| #11 |
Brian Doughty |
Irobot |
3 |
| #17 |
Jennifer H. Czerepinski |
Saint-Gobain Ceramics & Plastics |
2 |
| #17 |
Petr Kocis |
Alzheon |
2 |
| #17 |
Michael Andrew Kiebish |
Berg Companies |
2 |
| #17 |
Seth J. Bishop |
E Ink Holdings |
2 |
| #17 |
John H. Jones |
The Institute For Pharmaceutical Discovery |
2 |
| #17 |
Cheryl Larrivee-Elkins |
Taris Biomedical |
2 |
| #17 |
James Meador, III |
Momenta Pharmaceuticals |
2 |
| #17 |
Mark Raymond Blewett |
Bose |
2 |
| #17 |
Brett Haarala |
Covidien Lp |
2 |
| #17 |
Martin Tolar |
Alzheon |
2 |
| #17 |
Prakash Venkatanarayanan |
Dell Products |
2 |
| #17 |
Marco Fontecchio |
The Gillette Company |
2 |
| #17 |
Sara Lorene Simbeck |
RTX (Raytheon) |
2 |
| #17 |
Bryce A. Harrison |
Morphic Therapeutic |
2 |
| #17 |
Leslie Dakin |
Vertex Pharmaceuticals Incorporated |
2 |
| #17 |
Yingxuan Zhu |
Futurewei Technologies |
2 |
| #17 |
Richard Woessner |
Sharkninja Operating |
2 |
| #17 |
Steven J. Frank |
Ultrata |
2 |
| #17 |
Evan Belforti |
Reebok International Limited |
2 |
| #17 |
Aaron Mandell |
Quidnet Energy |
2 |
| #17 |
John Hey |
Alzheon |
2 |
| #17 |
Kanagasabai Sivanadian |
Rovi Guides |
2 |
| #17 |
Stephen W. Fitzpatrick |
AT&T |
2 |
| #17 |
Talha Riaz |
Boston Scientific Scimed |
2 |
| #17 |
John A. Hingston |
Boston Scientific Scimed |
2 |
| #17 |
Jinwang Xu |
Vertex Pharmaceuticals Incorporated |
2 |
| #43 |
Julius F. Remenar |
Alkermes Pharma Ireland Limited |
1 |
| #43 |
Benjamin James Moruzzi |
— |
1 |
| #43 |
Sornanathan Meyyappan |
Waters Technologies |
1 |
| #43 |
Greggory Nelson |
— |
1 |
| #43 |
Robert Lee Cardenas |
Foster-Miller |
1 |
| #43 |
Andreas Senai |
Cvs Pharmacy |
1 |
| #43 |
Katarzyna Handing |
Bayer Healthcare |
1 |
| #43 |
David Looney |
Imperial College Innovations |
1 |